COVID-19 ushered in a new era of clinical research, the biggest advantages of which are just beginning to surface. In 2021, the life sciences industry will see more remote trial designs adopted by a larger and broader group of sponsors, sites, and patients.
Director, Research & Academics
Medable
Decentralized Clinical Trials Expert, Vice President of DCT Innovation
Medable
Head of Decentralized Trials
Medable
Alison (Ali) Holland is Head of Decentralized and Remote trials at Medable and is chartered to design and expand the end-to-end capabilities needed to partially or fully virtualize clinical studies, building on the commitment to reduce clinical trial times by 50%. Ali has over 20 years of experience in a variety of leadership roles, including Feasibility Head and Six Sigma Black Belt at Covance, and Business Head and global General Manager at Roche/Genentech in one of their therapeutic area business groups. Having been engaged in over 300 studies across biotechs, pharma and all geographies, Ali brings an incomparable level of insight and technical excellence on the matter of operational needs for sites and patients.
Co-Founder and Chief Executive Officer
Medable Inc.
Michelle Longmire MD, is Co-founder and Chief Executive Officer of Medable. Dr. Longmire is a Stanford-trained physician-entrepreneur dedicated to transforming healthcare through innovation. Dr. Longmire has a background in epigenetics, novel diagnostics, and imaging. Dr. Longmire founded Medable in 2014 to enable healthcare technology to be as seamless, integrated, and adaptive as the human body.